Download PDF

Other users also viewed these articles

Optimal ALT threshold for the automated diagnosis of MASLD: A population-based study using iLFT Jeremy Lee; Christopher J. Byrne; Paul N. Brennan; Iain MacPherson; Eleanor Dow; John F. Dillon;
Ann Hepatol. 2024;29:
Prevalence of non-alcoholic fatty liver disease and liver fibrosis in a general population cohort from Argentina Federico Guillermo Villamil; Manuel Barbero; Nancy Elena Massenzio; Sandra Mónica Giani; Shigeru Kozima; Fernando Mario Cairo; Rodrigo Agustín Belloni; Javier Mariani; Mercedes Rodriguez Gazari; Paola Evangelina Coisson; Sonia Carolina Gallardo; Paula Andrea Cocco; Claudia Mabel Riboldi; Patricia Eugenia Gallardo;
Ann Hepatol. 2023;28:
Epidemiology and etiologic trends of hepatocellular carcinoma in cirrhotic patients in Mexico: a multicenter retrospective study (2018¿2024) Nahum Méndez-Sánchez; Mariana M. Ramírez-Mejía; Carlos Cortez-Hernández; Elianee M. Tovar-Bojorquez; Raúl Contreras-Omaña; Juan D. Monsiváis-Morales; Jacqueline Cordova-Gallardo; Mauricio Castillo-Barradas; Nubia Guzmán-Rodríguez; María S. González-Huezo; Adrian Sandez-Araiza; Eira Cerda-Reyes; Stefanny Cornejo-Hernández; Beatriz Barranco-Fragoso; Ana D. Cano-Contreras; José M. Remes-Troche; Fatima Higuera-de-la-Tijera; José L. Pérez-Hernández; Norberto Chávez-Tapia; Francisco J. Valentin-Cortez; Iaarah Montalvo-Gordon; Rubén R. Lozano-Salazar; Montserrat Sabanes-Hernández; Itziar Borbolla-Schega; Heriberto Rodríguez-Hernández;
10.1016/j.aohep.2025.102131